The Japan molecular diagnostics market reached USD 1.2 billion in 2024 and is expected to grow to USD 2.1 billion by 2033, with a CAGR of 6% from 2025 to 2033, according to IMARC Group. Key growth drivers include the rising prevalence of chronic diseases like cancer and cardiovascular conditions, the growing geriatric population with unique healthcare needs, and the adoption of advanc... https://www.imarcgroup.com/japan-molecular-diagnostics-market